Market Cap $11 M --Cash $18 M --Shares Out only 8.5M --2 BIG Phase 3 Readouts targeting posttraumatic stress disorder (PTSD) & Fibromyalgia which are very large markets expected in 1H 2020 .Phase 3 interim results of the PTSD trial expected during this Quarter . TNXP another BRUTALLY underpriced stock which could hit $10+ in the coming weeks .SUPER STRONG BUY at this ridiculous low price .GL Tonix Pharma (TNXP) Market Cap: $11 M Cash: $18 M Price:$1.28 M Shares Out: 8.5 M Presentation December https://content.equisolve.net/tonixpharma/media/ee42c8810e53a28b660086567f54bb25.pdf Insider buying http://openinsider.com/search?q=tnxp BIG Pipeline Pipeline Summary Financial Overview
